Artikel (Klinikum der LMU)

Ben Khaled, Najib; Ehmer, Ursula; Kubisch, Ilja; Gonzalez-Carmona, Maria A.; Philipp, Alexander; Seidensticker, Max; Altenhofer, Julia; Basch, Marion; Hüwer, Tim; Oehrle, Bettina; Geier, Andreas; Soldà, Caterina; Auriemma, Alessandra; Bauer, Ulrike; Zhou, Taotao; Perkhofer, Lukas; Chater, Jack; Weinmann, Arndt; Felden, Johann von; De Rosa, Antonio; Vivaldi, Caterina; Piseddu, Ignazio; Schwald, Isabel; Enssle, Stefan; Karin, Monika; Schneider, Julia S.; Gröper, Moritz N.; Ondrejkova, Katarina; Weiss, Lena; Beyer, Georg; Schulze, Kornelius; Antonuzzo, Lorenzo; Masi, Gianluca; Daniele, Bruno; Ricke, Jens; Mayerle, Julia; Foerster, Friedrich; Reiter, Florian P.; Ettrich, Thomas J.; De Toni, Enrico N. (2026): Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass). Therapeutic Advances in Medical Oncology, 18. pp. 1-14. ISSN 1758-8359

Dorman, Klara; Breitenwieser, Kilian; Fischer, Laura; Zhang, Danmei; Probst, Victoria; Weiss, Lena; Heinrich, Kathrin; Kunz, Wolfgang G. ORCID: 0000-0002-5021-1952; Holch, Julian W.; Gießen-Jung, Clemens; Haas, Michael; Boeck, Stefan; Bergwelt-Baildon, Michael von; Landfarth, Timotheus; Hornung, Roman; Casuscelli, Jozefina; Berger-Thürmel, Karin; Heinemann, Volker; Westphalen, C. Benedikt; Reischer, Anna (2025): Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic. Scientific Reports, 15: 43269. ISSN 2045-2322